The coronary drug project. Design, methods, and baseline results.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D003918:Dextrothyroxine / Q000627:therapeutic use; D004562:Electrocardiography; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use; D010919:Placebos; D012107:Research Design; D012907:Smoking / Q000453:epidemiology; D014280:Triglycerides / Q000097:blood; D014481:United States; D014527:Uric Acid / Q000097:blood
D000924:Anticholesteremic Agents; D001786:Blood Glucose; D004967:Estrogens; D009539:Nicotinic Acids; D010919:Placebos; D014280:Triglycerides; D014527:Uric Acid; D003918:Dextrothyroxine; D002784:Cholesterol; D000469:Alkaline Phosphatase; D002994:Clofibrate; D001663:Bilirubin